A recent study proposed the combination of different epigenetic drugs as a promising anti-tumor therapy by blocking the expression of several members of the histone deacetylase (HDAC) family to alter the function of both PMN-MDSCs and M-MDSCs (59). Here, HDAC9 is linked to neoplasm.